Metamizole and risk of hepatotoxicity –comparative cohort study of incidence of hepatic events in patients treated with metamizole vs. patients treated with paracetamol in IMS Disease Analyzer Germany between January 2009 and December 2018 (Metamizole and hepatotoxicity)

18/10/2019
02/04/2024
EU PAS number:
EUPAS31864
Study
Finalised
Documents
Study protocol
Initial protocol
English (233.46 KB - PDF) View document
Study results
Study report
Other information
Publications